Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Occupational Asthma.

Farooqui N, Peden D.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):783-4. doi: 10.1016/j.jaip.2015.12.009. No abstract available.

PMID:
27393786
2.

Low-Power Wearable Systems for Continuous Monitoring of Environment and Health for Chronic Respiratory Disease.

Dieffenderfer J, Goodell H, Mills S, McKnight M, Yao S, Lin F, Beppler E, Bent B, Lee B, Misra V, Zhu Y, Oralkan O, Strohmaier J, Muth J, Peden D, Bozkurt A.

IEEE J Biomed Health Inform. 2016 Sep;20(5):1251-1264. doi: 10.1109/JBHI.2016.2573286.

PMID:
27249840
3.

Clinically focused exome sequencing identifies an homozygous mutation that confers DOCK8 deficiency.

Burbank AJ, Shah SN, Montgomery M, Peden D, Tarrant TK, Weimer ET.

Pediatr Allergy Immunol. 2016 Feb;27(1):96-8. doi: 10.1111/pai.12451. No abstract available.

4.

Severe DRESS syndrome managed with therapeutic plasma exchange.

Alexander T, Iglesia E, Park Y, Duncan D, Peden D, Sheikh S, Ferris M.

Pediatrics. 2013 Mar;131(3):e945-9. doi: 10.1542/peds.2012-2117.

5.

Inflammatory cytokine response to ambient particles varies due to field collection procedures.

McConnell R, Wu W, Berhane K, Liu F, Verma G, Peden D, Diaz-Sanchez D, Fruin S.

Am J Respir Cell Mol Biol. 2013 Apr;48(4):497-502. doi: 10.1165/rcmb.2012-0320OC.

6.

Role of GSTM1 in resistance to lung inflammation.

Wu W, Peden D, Diaz-Sanchez D.

Free Radic Biol Med. 2012 Aug 15;53(4):721-9. doi: 10.1016/j.freeradbiomed.2012.05.037. Review.

7.

Asthma outcomes: exacerbations.

Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983. Review.

8.

Environmental and occupational allergies.

Peden D, Reed CE.

J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S150-60. doi: 10.1016/j.jaci.2009.10.073. Review.

PMID:
20176257
9.

Combination treatment with high-dose vitamin C and alpha-tocopherol does not enhance respiratory-tract lining fluid vitamin C levels in asthmatics.

Hernandez M, Zhou H, Zhou B, Robinette C, Crissman K, Hatch G, Alexis NE, Peden D.

Inhal Toxicol. 2009 Feb;21(3):173-81. doi: 10.1080/08958370802161077 .

10.

Advances in environmental and occupational respiratory disease in 2007.

Bush RK, Peden D.

J Allergy Clin Immunol. 2008 Jun;121(6):1359-62. doi: 10.1016/j.jaci.2008.03.034. Review.

PMID:
18539192
11.

Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.

Esch RE, Bush RK, Peden D, Lockey RF.

Ann Allergy Asthma Immunol. 2008 May;100(5):475-81. doi: 10.1016/S1081-1206(10)60474-7.

PMID:
18517081
12.

Circulating neutrophil CD14 expression and the inverse association of ambient particulate matter on lung function in asthmatic children.

Svendsen ER, Yeatts KB, Peden D, Orton S, Alexis NE, Creason J, Williams R, Neas L.

Ann Allergy Asthma Immunol. 2007 Sep;99(3):244-53.

PMID:
17910328
13.

The influence of variation in type and pattern of symptoms on assessment in pediatric asthma.

Fuhlbrigge AL, Guilbert T, Spahn J, Peden D, Davis K.

Pediatrics. 2006 Aug;118(2):619-25.

PMID:
16882815
14.

Nasal responses in asthmatic and nonasthmatic subjects following exposure to diesel exhaust particles.

Kongerud J, Madden MC, Hazucha M, Peden D.

Inhal Toxicol. 2006 Aug;18(9):589-94.

PMID:
16864550
15.

How exposures to biologics influence the induction and incidence of asthma.

Zeldin DC, Eggleston P, Chapman M, Piedimonte G, Renz H, Peden D.

Environ Health Perspect. 2006 Apr;114(4):620-6. Review.

16.

Incidence of allergy and allergy symptoms among workers exposed to laboratory animals.

Elliott L, Heederik D, Marshall S, Peden D, Loomis D.

Occup Environ Med. 2005 Nov;62(11):766-71.

17.

Progression of self-reported symptoms in laboratory animal allergy.

Elliott L, Heederik D, Marshall S, Peden D, Loomis D.

J Allergy Clin Immunol. 2005 Jul;116(1):127-32.

PMID:
15990785
18.

Gene-environment interactions in asthma and other respiratory diseases.

Kleeberger SR, Peden D.

Annu Rev Med. 2005;56:383-400. Review.

PMID:
15660518
19.

Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.

Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P.

J Asthma. 2004;41(8):797-806.

PMID:
15641629
20.

Health effects of air pollution.

Bernstein JA, Alexis N, Barnes C, Bernstein IL, Bernstein JA, Nel A, Peden D, Diaz-Sanchez D, Tarlo SM, Williams PB.

J Allergy Clin Immunol. 2004 Nov;114(5):1116-23. Review.

PMID:
15536419
Items per page

Supplemental Content

Loading ...
Support Center